|
|
|
| home > white papers > Key to Outsourcing Method Development and Validation: A Pragmatic Approach - RSSL |
|
|
 WHITE PAPERS |
|
RSSL
|
+44 (0)118 918 4024
|
|
http://www.rssl.com
|
|
University of Reading, Whiteknights Rd, Reading, West Berkshire RG6 6LA
|
|
|
Key to Outsourcing Method Development and Validation: A Pragmatic Approach
|
|
In an industry that is seeing an increasing level of work being
outsourced, the Contract Research Organisation (CRO) of choice needs to
have proven experience in both the pragmatism and flexibility of the
method developer’s mind set and a regulatory background in validation.
As
companies are focussing on achieving ever shorter times of drug to
market, it is vital that a tailored, pragmatic approach is adopted when
engaging in both method development and validation activities for an
Active Pharmaceutical Ingredient (API) or drug product (DP).
Although
methods still require a high degree of robustness, the overall strategy
should encompass a full evaluation of the regulatory requirements
applicable to the particular phase of the drug life-cycle; this is
pivotal in Key to Outsourcing Method Development and Validation A
Pragmatic Approach order to ensure a successful regulatory submission,
where the applicant must demonstrate suitable validation of all methods
used to support the filing.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Biopharma Group Celebrates Its 30th Anniversary
Established in 1989 as Biopharma Process Systems Ltd., the company
initially focused on freeze drying equipment to the pharmaceutical &
biotechnology industries and fast became a leading supplier of
equipment in the UK & Ireland. In 1997, Biopharma Technology Ltd.
was formed to offer a freeze drying R&D consultancy and lab
services, with Dr. Kevin Ward joining the team in 2000 to expand the
in-house expertise, services and training courses.
More info >> |
|
 |
White Papers |
 |
|
The Role of the CRO in Effective Risk-Based Monitoring
Medpace
The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >> |
|
 |
Industry Events |
 |
LogiPharma 2019
9-11 April 2019, Montreux Music & Convention Centre
LogiPharma
is the world’s leading pharma supply chain event. With over 950+ pharma supply
chain leaders exclusively meeting in one place at one time, LogiPharma is THE
meeting place to benchmark your business with the best pharma companies and
shape the future of your industry.
More info >> |
|
|
|
